Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4333-4338, October 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasegawa, R.
Right arrow Articles by Shirai, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasegawa, R.
Right arrow Articles by Shirai, T.

Increased Risk of Mammary Carcinoma Development following Transplacental and Trans-Breast Milk Exposure to a Food-derived Carcinogen, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in Sprague-Dawley Rats1

Ryohei Hasegawa2, Juki Kimura, Makoto Yaono, Satoru Takahashi, Toshio Kato, Mitsuru Futakuchi, Masato Fukutake, Kazuo Fukutome, Keiji Wakabayashi, Takashi Sugimura, Nobuyuki Ito and Tomoyuki Shirai

First Department of Pathology, Nagoya City University Medical School [R. H., J. K., M. Y., S. T., T. K., Mi. F., T. Sh.] and Nagoya City University [N. I.], 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, and Biochemistry Division, National Cancer Center Research Institute [Ma. F., K. F., K. W.] and National Cancer Center [T. Su.], 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104, Japan

Effects of transplacental and trans-breast milk exposure to a food-derived mammary and colon carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), were investigated in rats. Female Sprague-Dawley rats were administered PhIP in the diet (100 ppm) for 4 weeks before mating with nontreated males and also during gestation and lactation. As controls, additional females were maintained on the basal diet without PhIP and mated as with the treated animals. The offspring of both groups were subdivided for each sex at weaning into three dietary groups receiving 100, 25, and 0 ppm and were killed at 47 weeks of age. Effects of the transplacental and neonatal exposure to PhIP on mammary carcinogenesis were most evident in females administered 25 ppm PhIP after weaning; the incidence and multiplicity of adenocarcinomas in offspring from the PhIP fed dams (42.9%, 0.62/rat) was significantly higher than the value for offspring from nontreated dams (4.8%, 0.05/rat). Furthermore, in the basal diet groups, the incidence of adenocarcinomas in females was higher, albeit not significantly, in offspring of the PhIP-treated than the nontreated dams (16.7%, 0.22/rat as compared with 3.3%, 0.07/rat). Although the highest incidence of mammary adenocarcinomas was found in the female progeny given 100 ppm PhIP from PhIP-treated dams (70.0%, 1.55/rat), this was only slightly higher than the 61.9% and 0.90/rat of the same dose group from the nontreated dams. In males, no apparent effects of transplacental and neonatal exposures were evident. In a separate experiment, excretion of PhIP into breast milk and transfer of PhIP to fetuses and neonates with resultant hepatic PhIP-DNA adduct formation were demonstrated. Thus, maternal exposure to this food-derived carcinogen may be a critical risk factor for generation of mammary carcinomas.

1 Supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Science and Culture, and the Ministry of Health and Welfare of Japan, and grants from the Society for Promotion of Pathology of Nagoya, Japan.

2 To whom requests for reprints should be addressed.

Received 6/ 8/95. Accepted 8/ 2/95.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
D. J. Castro, W. M. Baird, C. B. Pereira, J. Giovanini, C. V. Lohr, K. A. Fischer, Z. Yu, F. J. Gonzalez, S. K. Krueger, and D. E. Williams
Fetal Mouse Cyp1b1 and Transplacental Carcinogenesis from Maternal Exposure to Dibenzo(a,l)pyrene
Cancer Prevention Research, July 1, 2008; 1(2): 128 - 134.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. N. Lauber and N. J. Gooderham
The Cooked Meat Derived Genotoxic Carcinogen 2-Amino-3-Methylimidazo[4,5-b]Pyridine Has Potent Hormone-Like Activity: Mechanistic Support for a Role in Breast Cancer
Cancer Res., October 1, 2007; 67(19): 9597 - 9602.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
S. Taguchi, K. Kuriwaki, M. Souda, M. Funato, K. Ninomiya, Y. Umekita, and H. Yoshida
Induction of Sarcomas by a Single Subcutaneous Injection of 7,12-Dimethylbenz[a]anthracene into Neonatal Male Sprague-Dawley Rats: Histopathological and Immunohistochemical Analyses
Toxicol Pathol, June 1, 2006; 34(4): 336 - 347.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Yu, C. V. Loehr, K. A. Fischer, M. A. Louderback, S. K. Krueger, R. H. Dashwood, N. I. Kerkvliet, C. B. Pereira, J. E. Jennings-Gee, S. T. Dance, et al.
In utero Exposure of Mice to Dibenzo[a,l]Pyrene Produces Lymphoma in the Offspring: Role of the Aryl Hydrocarbon Receptor
Cancer Res., January 15, 2006; 66(2): 755 - 762.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Fang, R. J. Edwards, M. Bartlet-Jones, G. W. Taylor, S. Murray, and A. R. Boobis
Urinary N2-(2'-deoxyguanosin-8-yl)PhIP as a biomarker for PhIP exposure
Carcinogenesis, June 1, 2004; 25(6): 1053 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. M. Gressani, S. Leone-Kabler, M. G. O'Sullivan, A. J. Townsend, and M. S. Miller
Prenatal Toxicity and Lack of Carcinogenicity of 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) following Transplacental Exposure
Toxicol. Sci., June 1, 2000; 55(2): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Y. Ikeda, S. Takahashi, J. Kimura, Y.-M. Cho, K. Imaida, S. Shirai, and T. Shirai
Anophthalmia in Litters of Female Rats Treated with the Food-Derived Carcinogen, 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine
Toxicol Pathol, November 1, 1999; 27(6): 628 - 631.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
J. E. Paulsen, I.-L. Steffensen, A. Andreassen, R. Vikse, and J. Alexander
Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice
Carcinogenesis, July 1, 1999; 20(7): 1277 - 1282.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.